Oxford Biomedica Regulatory News (OXB)



Regulatory News for Oxford Biomedica (OXB)


Share Price: 1.685Bid: 1.65Ask: 1.72Change: -0.015 (-0.88%)Faller - Oxford Biomed.
Spread: 0.07Spread as %: 4.24%Open: 1.65High: 0.00Low: 0.00Yesterday’s Close: 1.70





Block Listing Six Monthly Return

Thu, 26th May 2011 07:00

RNS Number : 3078H
Oxford Biomedica PLC
26 May 2011
 

 

For Immediate Release

26 May 2011

 

 

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Share Option Scheme

Period of return:

From:

27 November 2010

To:

26 May 2011

Balance of unallotted securities under scheme(s) from previous return:

3,854,647 Ordinary Shares of 1p each

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

None

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

None

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

3,854,647 Ordinary Shares of 1p each

 

Name of contact:

Andrew Wood, Company Secretary

Telephone number of contact:

01865 783000

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRDKPDQABKDNPB


Related Shares: Oxford Biomedica (OXB).




DateSourceHeadlineCategory
12-Jun-13 07:00RNSDirectors' Interests in Share OptionsDirectors' Dealings
10-Jun-13 12:59RNSDirector/PDMR ShareholdingDirectors' Dealings
10-Jun-13 12:59RNSTR-1: Notification of Major Interest in SharesHolding(s) in Company
10-Jun-13 07:00RNSDirector's Share PurchaseDirectors' Dealings
06-Jun-13 11:45RNSResult of AGMResults and Trading Reports
06-Jun-13 07:00RNSChange of Adviser and BrokerExecutive Changes
06-Jun-13 07:00RNSManagement and Board changeExecutive Changes
05-Jun-13 10:43RNSTR-1: Notification of Major Interest in SharesHolding(s) in Company
03-Jun-13 07:00RNSClinical Trial UpdateCompany Announcement - General
24-May-13 10:00RNSBLOCK LISTING RETURNCompany Announcement - General
16-May-13 07:00RNSInterim Management StatementResults and Trading Reports
09-May-13 09:00RNS-RUpdate from ARVO 2013Company Announcement - General
03-May-13 14:00RNSDirector/PDMR ShareholdingDirectors' Dealings
03-May-13 14:00RNSHolding(s) in CompanyHolding(s) in Company
01-May-13 07:03RNSCollaboration with NovartisCompany Announcement - General
17-Apr-13 13:00RNS2012 ANNUAL REPORT & ACCOUNTS & AGM NOTIFICATIONResults and Trading Reports
07-Mar-13 07:00RNS-RInitiation of PII Collaborative Study for TroVaxCompany Announcement - General
27-Feb-13 07:00RNSPreliminary ResultsResults and Trading Reports
25-Jan-13 16:40RNSSecond Price Monitoring ExtnCompany Announcement - General
25-Jan-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
23-Jan-13 07:00RNSNotice of Preliminary ResultsAdvance Notice of Results
29-Nov-12 07:00RNSExercise of Option by ImaginAbCompany Announcement - General
28-Nov-12 07:00RNSBlock Listing ReturnCompany Announcement - General
20-Nov-12 07:00RNSOcular Clinical Programme UpdateCompany Announcement - General
14-Nov-12 07:00RNSInterim Management StatementCompany Announcement - General
09-Nov-12 07:00RNSIssue of Key US PatentCompany Announcement - General
10-Oct-12 07:00RNSUpdate on TroVax (R) Development StrategyCompany Announcement - General
03-Oct-12 07:00RNSBoard ChangeCompany Announcement - General
27-Sep-12 08:00RNS-RCollaboration With Immune Design Corp.Company Announcement - General
26-Sep-12 16:40RNSSecond Price Monitoring ExtnCompany Announcement - General


Regulatory news is displayed end of day, each day at 19:00.
Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.